BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16806002)

  • 21. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
    Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
    Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
    Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
    Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of supplemental chromium on interferon-gamma (IFN-gamma) mRNA expression in response to Newcastle disease vaccine in broiler chicken.
    Bhagat J; Ahmed KA; Tyagi P; Saxena M; Saxena VK
    Res Vet Sci; 2008 Aug; 85(1):46-51. PubMed ID: 17888472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
    Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
    Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses.
    McGuire TC; Zhang W; Hines MT; Henney PJ; Byrne KM
    Virology; 1997 Nov; 238(1):85-93. PubMed ID: 9375012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of two synthetic peptides mimicking conserved regions of equine infectious anemia virus proteins gp90 and gp45 upon cytokine mRNA expression.
    Bailat AS; Soutullo AR; García MI; Veaute CM; Garcia L; Racca AL; Malan Borel IS
    Arch Virol; 2008; 153(10):1909-15. PubMed ID: 18825485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo pretreatment with PGG-glucan fails to alter cytokine mRNA expression of equine peripheral blood mononuclear cells exposed to endotoxin ex vivo.
    Sykes BW; Furr M; Giguère S
    Vet Ther; 2005; 6(1):67-76. PubMed ID: 15906271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
    Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
    Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
    Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the pathogenicity of African Horsesickness (AHS) isolates in vaccinated animals.
    von Teichman BF; Smit TK
    Vaccine; 2008 Sep; 26(39):5014-21. PubMed ID: 18682269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
    Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.
    Jin S; Issel CJ; Montelaro RC
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1120-9. PubMed ID: 15539516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combination immunization with EIAV Env protein expressed by recombinant baculovirus and recombinant vaccinia virus containing env gene].
    Dai CM; Zhang XY; Zhang RR; Shao YM; Shen RX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):410-4. PubMed ID: 15207082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.